{"generic":"Sodium Thiosulfate","drugs":["Sodium Thiosulfate"],"mono":{"0":{"id":"557000-s-0","title":"Generic Names","mono":"Sodium Thiosulfate"},"1":{"id":"557000-s-1","title":"Dosing and Indications","sub":{"0":{"id":"557000-s-1-4","title":"Adult Dosing","mono":"<ul><li><b>Cisplatin nephropathy; Prophylaxis:<\/b> 9 g\/m(2) IV push, then 1.2 g\/m(2)\/hr continuous infusion for 6hrs<\/li><li><b>Cyanide poisoning:<\/b> 12.5 g IV over 10 min (after sodium nitrite 300 mg); repeat, if necessary, with half doses of both<\/li><\/ul>"},"1":{"id":"557000-s-1-5","title":"Pediatric Dosing","mono":"<b>Cyanide poisoning:<\/b> 412.5 mg\/kg of body weight or 7 g\/m(2) administered at a rate of 0.625 to 1.25 g\/min IV"},"3":{"id":"557000-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><ul><li>Cisplatin nephropathy; Prophylaxis<\/li><li>Cyanide poisoning<\/li><\/ul><b>Non-FDA Labeled Indications<\/b><ul><li>Antineoplastic adverse reaction - Injection site extravasation<\/li><li>Calciphylaxis<\/li><li>Carboplatin adverse reaction - Ototoxicity<\/li><\/ul>"}}},"3":{"id":"557000-s-3","title":"Contraindications\/Warnings","sub":[{"id":"557000-s-3-9","title":"Contraindications","mono":"Previous hypersensitivity to sodium thiosulfate<br\/>"},{"id":"557000-s-3-10","title":"Precautions","mono":"Extravasation<br\/>"},{"id":"557000-s-3-11","title":"Pregnancy Category","mono":"C (FDA)<br\/>"},{"id":"557000-s-3-12","title":"Breast Feeding","mono":"<ul><li>WHO: WHO documentation states insufficient data.<\/li><li>Micromedex: Infant risk cannot be ruled out.<\/li><\/ul>"}]},"5":{"id":"557000-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Dermatologic:<\/b>Contact dermatitis<\/li><li><b>Gastrointestinal:<\/b>Diarrhea<\/li><\/ul>"},"6":{"id":"557000-s-6","title":"Drug Name Info","sub":{"2":{"id":"557000-s-6-19","title":"Class","mono":"Cyanide Antidote<br\/>"},"3":{"id":"557000-s-6-20","title":"Regulatory Status","mono":"RX\/OTC<br\/>"},"4":{"id":"557000-s-6-21","title":"Generic Availability","mono":"Yes<br\/>"}}},"9":{"id":"557000-s-9","title":"Administration","mono":"<b>Intravenous<\/b><br\/>slow administration over 10 minutes<br\/>"},"10":{"id":"557000-s-10","title":"Monitoring","mono":"reduced symptoms of cyanide poisoning; for 24 to 48 hours after therapy <br\/>"},"11":{"id":"557000-s-11","title":"How Supplied","mono":"<b>Generic<\/b><br\/>Intravenous Solution: 250 MG\/ML<br\/>"},"12":{"id":"557000-s-12","title":"Toxicology","sub":[{"id":"557000-s-12-31","title":"Clinical Effects","mono":"<b>SODIUM THIOSULFATE<\/b><br\/>OVERDOSE: Sodium thiosulfate is an agent with a low order of toxicity.  It may be a mild irritant in the solid form.  Dust and concentrated solutions can irritate the skin, eyes and mucous membranes. Allergic dermatitis has also been reported. Ingestion of large amounts may cause gastrointestinal irritation, nausea, vomiting, abdominal cramping and diarrhea. Hypotension is only predicted following rapid intravenous infusion of very large doses and should be self-limited and transient.<br\/>"},{"id":"557000-s-12-32","title":"Treatment","mono":"<b>SODIUM THIOSULFATE <\/b><br\/><ul><li>Decontamination: ORAL: Activated charcoal.<\/li><li>Hypotensive episode: IV 0.9% NaCl, dopamine or norepinephrine. Hypotension is predicted to only follow rapid intravenous infusion of very large doses and should be self-limited and transient.<\/li><li>Monitoring of patient: Monitor vital signs, ECG, acid-base and fluid\/electrolyte status as indicated.<\/li><\/ul>"},{"id":"557000-s-12-33","title":"Range of Toxicity","mono":"<b>SODIUM THIOSULFATE<\/b><br\/>TOXICITY: Ingestion of 12 g of sodium thiosulfate was virtually non-toxic except for producing violent catharsis. The lowest toxic intravenous doses for humans were 0.2 to 1.5 g\/kg.   As much as 9.9 g\/m(2) has been given IV with no apparent ill effects. THERAPEUTIC: Adults - Cisplatin nephropathy: 9 g\/m(2) IV push, then 1.2 g\/m(2)\/hr continuous infusion for 6 hrs; Cyanide poisoning: 12.5 g IV over 10 minutes (after sodium nitrite 300 mg); repeat, if necessary, with half doses of both. Children - Cyanide poisoning: 412.5 mg\/kg of body weight or 7 g\/m(2) administered at a rate of 0.625 to 1.25 g\/minutes IV.<br\/>"}]},"13":{"id":"557000-s-13","title":"Clinical Teaching","mono":"<ul><li>This drug may cause contact dermatitis or diarrhea.<\/li><li>Patient should report signs\/symptoms of extravasation.<\/li><\/ul>"}}}